Did you know?

2001: The FDA approves Gleevec®, a drug developed by LLS-funded researcher Brian Druker, M.D., to treat patients with CML and other blood cancers.

The Word:

promo_left_donate

Media Room

The Leukemia & Lymphoma Society welcomes inquiries from members of the media. We're available to discuss story ideas about blood cancer, connect you with a patient or medical expert/researcher and more.

You can reach us between 9 a.m. and 5 p.m. ET, Monday through Friday:

We can also provide:

last updated on Tuesday, December 11, 2012
btn_sharethis

E-Newsletters


Sign Up For Free

Subscribe to one of LLS's Monthly eNewsletters
Your Name

Your Email

Your Zip Code


About E-News»